Posaconazole Tablet, Delayed Release
Product Images NDC 71335-2930

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 71335-2930). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352930)

Posaconazole delayed-release tablets, 100 mg strength, labeled for oral use. The label shows the product NDC 71335-2930-1 and indicates a package containing 60 tablets. It is relabeled by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by i3 Pharmaceuticals, LLC. Storage instructions and a caution about non-interchangeability with Noxafil oral suspension are also displayed.*

FDA Label Image

Structure (Structure)

Chemical structure of Posaconazole displayed as a 2D molecular diagram showing its atomic connectivity and ring systems.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.